Back to Search
Start Over
AstraZeneca's Tezspire receives European approval to treat severe asthma
- Source :
- PharmaBiz. September 22, 2022
- Publication Year :
- 2022
-
Abstract
- AstraZeneca's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on maintenance treatment in patients 12 years and older with severe asthma who are inadequately controlled with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.718972941